Harvard Pilgrim Health Care

Clinical Trial by Harvard Pilgrim Health Care Institute, HCA Healthcare, UCI Health and CDC Identifies Strategy to Rapidly Detect and Respond to Hospital Outbreaks Using Algorithm-Driven Technology

Retrieved on: 
Tuesday, April 23, 2024

The large multi-state, real-world study was conducted in 82 hospitals and led by Harvard Pilgrim Health Care Institute, HCA Healthcare, University of California, Irvine (UCI) Health and the Centers for Disease Control and Prevention (CDC).

Key Points: 
  • The large multi-state, real-world study was conducted in 82 hospitals and led by Harvard Pilgrim Health Care Institute, HCA Healthcare, University of California, Irvine (UCI) Health and the Centers for Disease Control and Prevention (CDC).
  • While hospitals and health systems work to prevent infections and reduce the opportunity for outbreaks to occur, there is no standardized approach for detecting transmission.
  • Early detection can lead to a rapid response that reduces the chance for outbreaks to occur.
  • “The CLUSTER trial provides evidence that early detection powered by automation tools and quick action can prevent outbreaks from growing."

Two Clinical Trials Identify a Better Way to Target Appropriate Antibiotics for Patients Hospitalized With Pneumonia or Urinary Tract Infection

Retrieved on: 
Friday, April 19, 2024

The two newly published studies, the INSPIRE Pneumonia and UTI Trials, involved more than 220,000 patients with pneumonia or UTI in 59 HCA Healthcare hospitals.

Key Points: 
  • The two newly published studies, the INSPIRE Pneumonia and UTI Trials, involved more than 220,000 patients with pneumonia or UTI in 59 HCA Healthcare hospitals.
  • This resulted in a better match for 28% of pneumonia patients and 17% of patients with UTI when compared to hospitals where physicians were not provided with alerts according to the trials.
  • The INSPIRE trials identified patients with low risk for antibiotic resistance and prompted physicians to order standard-spectrum antibiotics if extended-spectrum antibiotics were being ordered.
  • Additional information about the INSPIRE Pneumonia and UTI Trials can be found in the following JAMA author interview podcast.

Point32Health to Eliminate Prior Authorizations for Home Health Care Services

Retrieved on: 
Tuesday, April 2, 2024

CANTON, Mass. and BOSTON, April 2, 2024 /PRNewswire/ -- Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, announced today that it is updating its prior authorization requirements for home health care services for members in its commercial plans. Beginning April 12, home care services will not require utilization management for the first 30 days after one of the company's members is discharged from a hospital.

Key Points: 
  • and BOSTON, April 2, 2024 /PRNewswire/ -- Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, announced today that it is updating its prior authorization requirements for home health care services for members in its commercial plans.
  • Beginning April 12, home care services will not require utilization management for the first 30 days after one of the company's members is discharged from a hospital.
  • "We realize the administrative burden that prior authorization requirements can cause providers as well as our members.
  • Currently, skilled services provided in the home (physical therapy, occupational therapy, and speech-language pathology services; social work visits; home health aides; skilled nursing; nutritional counseling) require prior authorization after the initial evaluation for Harvard Pilgrim and Tufts Health Plan plans.

meQuilibrium Selected by Point32Health to Support Emotional Health and Well-being of Their Colleagues

Retrieved on: 
Wednesday, January 24, 2024

BOSTON, Jan. 24, 2024 /PRNewswire/ -- meQuilibrium (meQ) has been selected by Point32Health, the parent company of Harvard Pilgrim and Tufts Health Plan, to support the mental well-being of colleagues within its family of companies.

Key Points: 
  • BOSTON, Jan. 24, 2024 /PRNewswire/ -- meQuilibrium (meQ) has been selected by Point32Health, the parent company of Harvard Pilgrim and Tufts Health Plan, to support the mental well-being of colleagues within its family of companies.
  • Point32Health colleagues can now access meQ to navigate challenges and build their adaptive capacity, resilience, and agility.
  • "At Point32Health, we strive to offer innovative tools that guide better health outcomes for our colleagues," said Pete Church, chief people officer, Point32Health.
  • The meQ solution is part of a comprehensive suite of benefits we offer to our colleagues with a goal of prioritizing their health and well-being."

CENTENE CORPORATION ANNOUNCES APPOINTMENT OF MICHAEL A. CARSON AS PRESIDENT AND CHIEF EXECUTIVE OFFICER OF ITS MEDICARE BUSINESS

Retrieved on: 
Monday, January 22, 2024

ST. LOUIS, Jan. 22, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced two appointments. Michael A. Carson joins Centene as President and Chief Executive Officer (CEO) of its Medicare business, Wellcare. Mr. Carson will be responsible for Medicare business performance, strategy and growth and will report to Centene President Ken Fasola. Carson succeeds Richard Fisher, who has been appointed to the Operations leadership team under Centene Chief Operating Officer Susan Smith. Mr. Fisher will have responsibility for key financial and operational processes across Shared Services, as well as lead enterprise development, management and optimization of Centene's key vendor partnerships.

Key Points: 
  • Michael A. Carson joins Centene as President and Chief Executive Officer (CEO) of its Medicare business, Wellcare .
  • Mr. Carson will be responsible for Medicare business performance, strategy and growth and will report to Centene President Ken Fasola.
  • Carson succeeds Richard Fisher, who has been appointed to the Operations leadership team under Centene Chief Operating Officer Susan Smith.
  • Mr. Carson also served as the CEO of Bright Health Plan and as the President and CEO of Harvard Pilgrim Health Care.

Point32Health and Monogram Health Expand Collaboration Aimed at Improving Chronic Kidney Care

Retrieved on: 
Tuesday, January 16, 2024

and NASHVILLE, Tenn., Jan. 16, 2024 /PRNewswire/ -- Point32Health , the parent company of Tufts Health Plan and Harvard Pilgrim Health Care, today announced an expansion of its relationship with Monogram Health , the nation's leading value-based provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney and end stage kidney disease to include members in its Tufts Health Direct population.

Key Points: 
  • and NASHVILLE, Tenn., Jan. 16, 2024 /PRNewswire/ -- Point32Health , the parent company of Tufts Health Plan and Harvard Pilgrim Health Care, today announced an expansion of its relationship with Monogram Health , the nation's leading value-based provider of in-home, evidence-based care and benefit management services for patients living with chronic kidney and end stage kidney disease to include members in its Tufts Health Direct population.
  • Point32Health and Monogram began working together in 2022 to improve early access to kidney care for Harvard Pilgrim Health Care and Tufts Health commercial members.
  • Through the expanded collaboration, Monogram Health will assume full financial risk for Tufts Health Direct members with kidney disease, delivering industry-leading in-home specialty care services, promoting better patient outcomes while improving affordability.
  • "This powerful collaboration with Point32Health expands Monogram's ability to transform health care for CKD and ESKD patients in the commercial space," said Aash Shah, MD, chief growth officer of Monogram Health.

Harvard Pilgrim Health Care Institute Appoints New President

Retrieved on: 
Thursday, January 11, 2024

CANTON, Mass., Jan. 11, 2024 /PRNewswire/ -- Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, today announced that Emily Oken, MD, MPH, has been appointed the new president of the Harvard Pilgrim Health Care Institute, following a nation-wide search. As part of her new role, Dr. Oken will also serve as chair of Harvard Medical School's Department of Population Medicine at the Harvard Pilgrim Health Care Institute.

Key Points: 
  • CANTON, Mass., Jan. 11, 2024 /PRNewswire/ -- Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, today announced that Emily Oken , MD, MPH, has been appointed the new president of the Harvard Pilgrim Health Care Institute, following a nation-wide search.
  • As part of her new role, Dr. Oken will also serve as chair of Harvard Medical School's Department of Population Medicine at the Harvard Pilgrim Health Care Institute.
  • Chan School of Public Health, and the Harvard Pilgrim Health Care Institute.
  • She is a professor of population medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute.

POINT32HEALTH EXPANDS PORTFOLIO TO OFFER POINT32HEALTH DENTAL AND POINT32HEALTH VISION

Retrieved on: 
Thursday, January 4, 2024

CANTON, Mass., Jan. 4, 2024 /PRNewswire/ -- Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, today announced an expansion of its portfolio to include Point32Health Dental and Point32Health Vision. The new dental and vision products will initially be offered to Harvard Pilgrim's commercial clients with 51 or more eligible members for enrollment in July 2024.

Key Points: 
  • CANTON, Mass., Jan. 4, 2024 /PRNewswire/ -- Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, today announced an expansion of its portfolio to include Point32Health Dental and Point32Health Vision.
  • The new dental and vision products will initially be offered to Harvard Pilgrim's commercial clients with 51 or more eligible members for enrollment in July 2024.
  • "As Point32Health continues to evolve, our portfolio of products and services are also growing to support employers' interest in offering comprehensive benefits to current and prospective employees," said Phil Barr, president, markets at Point32Health.
  • "We believe strongly that our new dental and vision products will deliver greater value to our employer clients with more opportunities to support their workforce."

Harvard Pilgrim Health Care, a Point32Health company, honors 53 physician groups in its 22nd annual Physician Group Honor Roll

Retrieved on: 
Wednesday, January 3, 2024

CANTON, Mass., Jan. 3, 2024 /PRNewswire/ -- A total of 53 physician groups in the Harvard Pilgrim commercial provider network have been named to Harvard Pilgrim Health Care's 22nd annual Physician Group Honor Roll.

Key Points: 
  • CANTON, Mass., Jan. 3, 2024 /PRNewswire/ -- A total of 53 physician groups in the Harvard Pilgrim commercial provider network have been named to Harvard Pilgrim Health Care's 22nd annual Physician Group Honor Roll.
  • The Harvard Pilgrim Honor Roll highlights physician groups that have achieved exceptional results in their approach to disease prevention and the treatment of acute and chronic illness for both adult and pediatric patients.
  • Harvard Pilgrim reviewed performance in three domains of clinical care affecting both adult and pediatric patients: acute, chronic and preventive care.
  • A total of 16 of the 53 practices on the Physician Group Honor Roll achieved "With Distinction" status, meaning they exceeded NCQA's national 90th percentile in these domains of clinical care.

Movn Health Selected as Winner of Point32Health's Second Innovation Challenge

Retrieved on: 
Tuesday, December 12, 2023

CANTON, Mass., Dec. 12, 2023 /PRNewswire/ -- Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, has announced Movn Health as the winner of its second annual Innovation Challenge.

Key Points: 
  • CANTON, Mass., Dec. 12, 2023 /PRNewswire/ -- Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, has announced Movn Health as the winner of its second annual Innovation Challenge.
  • Based in Irvine, California, Movn Health is a leading telehealth provider for remote cardiac rehab and prevention.
  • In partnership with health plans and providers, Movn helps close cardiovascular care gaps with an evidence-based approach.
  • The other two finalists of the second Innovation Challenge were Cognoa, based in Palo Alto, California, and Curio Digital Therapeutics , based in Princeton, NJ.